Researcher

Journal of Clinical Child & Adolescent Psychology
Published: April 2022
Substance use prevention, along with treatment and recovery support, is perhaps the most critical component of the public health approach needed to transform how our nation addresses addiction.
Substance use prevention, along with treatment and recovery support, is a key component of the public health approach needed to transform how our nation addresses addiction.
The Family Involvement in Recovery Support and Treatment (FIRST) Research Network is a multidisciplinary collaborative dedicated to promoting family integration in treatment and recovery services for youth with substance use disorders.
The Family Involvement in Recovery Support and Treatment (FIRST) Research Network is a multidisciplinary collaborative dedicated to promoting family integration in treatment and recovery services for youth with substance use disorders.
The Family Involvement in Recovery Support and Treatment (FIRST) Research Network is a multidisciplinary collaborative dedicated to promoting family integration in treatment and recovery services for youth with substance use disorders.
The Family Involvement in Recovery Support and Treatment (FIRST) Research Network is a multidisciplinary collaborative dedicated to promoting family integration in treatment and recovery services for youth with substance use disorders.
We conduct research and advance policy to ensure those affected by addiction get the care and support they need.
We conduct original research to improve the reach, accessibility and quality of substance use prevention, treatment and recovery services.
Medical necessity criteria should reflect generally accepted standards of care for the patient’s condition. Yet, for substance use disorders (SUDs), some health plans have used medical necessity criteria to restrict care and control costs.
Produced in collaboration with the Legal Action Center, this report analyzes requirements for public and private health plans to use specific criteria and assessment tools to determine medical necessity for substance use disorder benefits.
Traditional regulatory enforcement activities have proven inadequate to capture necessary compliance data or prevent the sale of sub-standard plans.